Saniona AB
Research Saniona AB (SANION) on Bullrun: market cap SEK 1.83B, P/E 8.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSANION
- ExchangeST
- CountryDenmark
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 1.83B
- P/E8.0
- Financial periodQ1 2026
- RevenueSEK 4.69M
- Net income-SEK 46.16M
- Free cash flow-SEK 51.66M
- Gross margin64.2%
Valuation Snapshot
latest market cap is SEK 1.83B; P/E is 8.0.
Peer valuation comparison
Latest P/E is 8x versus a Healthcare sector median of 24.46x (67.3% below).
Latest P/E is 8x versus a Denmark median of 19.06x (58.0% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 434.40M | SEK 284.67M | SEK 199.72M | 98.7% | 2.04 | SEK 580.82M | SEK 0 | SEK 635.16M |
| FY2024 | SEK 334.67M | SEK 188.71M | SEK 248.05M | n/a | 1.76 | SEK 303.26M | SEK 5.41M | SEK 231.82M |
| FY2023 | SEK 16.84M | -SEK 95.81M | -SEK 72.67M | n/a | -1.52 | SEK 30.96M | SEK 65.24M | -SEK 21.94M |
| FY2022 | SEK 15.28M | -SEK 211.57M | -SEK 282.52M | n/a | -3.39 | SEK 111.71M | n/a | SEK 52.71M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | SEK 1.83B | 8.0 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Saniona AB
Saniona AB (publ), a clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom. It also develops medicines modulating ion channels. The company's product includes Tesofensine, a monoamine reuptake inhibitor that has completed Phase 3 clinical trial to treat people with obesity;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Saniona AB's market cap?
Saniona AB's market capitalization is SEK 1.83B.
What is Saniona AB's P/E ratio?
Saniona AB's price-to-earnings (P/E) ratio is 8.0.
What does Saniona AB do?
Saniona AB (publ), a clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom. It also develops medicines modulating ion channels.